Nuclear polyhedrosis virus (NPVs) and granuloviruses (GVs) are members of the Baculoviridae which infect insects and other arthropods. All baculoviruses have a unique infection cycle in that they produce two infectious forms: a budded virus, which infects different cell types within a single larva; and an occlusion body, a form of the virus that is embedded in a protein structure. Larvae are infected upon ingestion of the occlusion body and release of the viral particles in the alkaline environment of the midgut. In NPVs, many viral particles are occluded in a single intranuclear crystal called a polyhedron, whereas in GVs a single viral particle is found in each crystal, or granule. The polyhedron protects the viral particles from environmental elements and is the viral form that is used for biocontrol of agricultural and forest insect pests (for a review see reference 10).
Enhancin, which has also been referred to as the synergistic or viral enhancing factor, is a protein found in the GV occlusion body that has the ability to enhance the infection of other NPVs (15, 18, 37, 40, 41) . The enhancin protein is highly expressed in GVs and makes up approximately 5% of the total protein in the granules (37) . It has been localized deep within the capsule matrix, close to the viral envelope (47, 49) . Purified enhancin from the Trichoplusia ni GV (TnGV) can enhance the infection of the Autographa californica NPV (AcMNPV) 2-to 4-fold when fed to T. ni larvae and up to 12-fold when fed to other larvae such as those of Spodoptera exigua (45) . Recently, enhancin genes have also been identified in the Pseudaletia unipuncta GV (PuGV) and the Helicoverpa armigera GV (HaGV) (32) .
Two modes of action have been observed for enhancin proteins. First, the enhancins exhibit proteolytic activity (16, 38) which results in the enzymatic hydrolysis of the peritrophic membrane (12, 45) , a barrier against microbial pathogens in the insect midgut. Degradation of the peritrophic membrane by enhancin is believed to allow the virus easier access to the midgut columnar cells, resulting in the insect's increased susceptibility to viral infection (12) . Second, there is an increased fusion of the nucleocapsids with the midgut cells through interaction of the enhancin protein with both the viral envelope and the cell plasma membrane (37, 39, 42, 45) .
The Lymantria dispar NPV (LdMNPV) is pathogenic to the gypsy moth, a forest and urban tree-defoliating pest in the northeastern United States. The genome of the LdMNPV is approximately 162 kbp in length (29) , in contrast to the 133-kbp genome of the prototype baculovirus, AcMNPV. The entire genome of the AcMNPV has been sequenced (2) , and although that of the LdMNPV is not as well characterized, several genes which are present in both the LdMNPV and the AcMNPV have been identified (6, 9, 31, 36) . The extra 29 kbp of DNA present in the LdMNPV suggests that this virus has the potential to possess several genes which are not present in the AcMNPV. Two genes, the host range factor 1 gene (43) and G22 (5) , that have been identified and characterized for the LdMNPV do not have homologs in the AcMNPV. In this study we extended the characterization of the LdMNPV by cloning and sequencing the enhancin gene. Homologs of this gene are present in the GVs but have not been identified in any other NPV to date. We also explored the effect of the LdMNPV enhancin protein on viral pathogenicity by inactivating the enhancin gene through insertional mutagenesis.
MATERIALS AND METHODS
Cells, virus, and insects. L. dispar 652Y cells were grown as monolayers in Goodwin's IPL-52B medium supplemented with 6.25 mM glutamine and 10% fetal bovine serum. Cell cultures were inoculated with either LdMNPV isolate A21-MPV (35) , which produces wild-type polyhedra, or the enhancin::cat virus (in which enhancin is disrupted by a chloramphenicol acetyltransferase [cat] gene). L. dispar egg masses were obtained from the U.S. Department of Agriculture's Animal and Plant Health Inspection Service rearing facility at Otis Air Force Base (Mass.). Hatched larvae were reared on a gypsy moth diet (3) .
Viral DNA isolation and Southern blot analysis. Budded virus was isolated from infected 652Y cells as described previously (4) and used as a source of genomic DNA for restriction analysis. Viral DNA was digested with restriction endonucleases and fractionated on 1.0% agarose-Tris-borate-EDTA gels. Southern blot analysis was performed on nitrocellulose with probes labeled with the nick translation kit (Bethesda Research Laboratories) and [␣-
32 P]dCTP (NEN).
Sequencing. The sequence of the enhancin gene from isolate A21-MPV was determined for both strands by the dideoxynucleotide sequencing method. Plasmid and single-strand M13 DNA templates were sequenced with the Sequenase version 2.0 DNA sequencing kit (U.S. Biochemicals) or the fmol DNA sequencing system (Promega) by using the protocols supplied with the kits. ␣-35 S-dATP was supplied by NEN. Sequence analysis was done with the MacVector program (International Biotechnologies, Inc.).
In vitro transcription and translation of the enhancin gene. A 4.2-kbp SstII fragment containing the enhancin gene was subcloned into pBluescript SKϩ (Stratagene) to generate pDB126. The enhancin protein was expressed from pDB126 with the T N T coupled reticulocyte lysate system and T7 RNA polymerase (Promega) per the directions provided with the kit. The expressed protein was labeled by the addition of [ 35 S]methionine (NEN). Reaction products were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and autoradiography.
RNA isolation and Northern blot analysis. A21-MPV-infected 652Y cells were harvested at various times postinfection (p.i.). Cytoplasmic RNA was isolated as described by Friesen and Miller (14) . RNA was separated on 1.2% agarose gels containing formaldehyde and transferred to nitrocellulose. Northern blot analysis was performed as described by Mahmoudi and Lin (28) . A 30-base oligonucleotide (complementary to positions 939 to 968 in Fig. 2 ) was end labeled with [␥-32 P]ATP (NEN) and used as a strand-specific probe to detect the enhancin transcripts.
Primer extension mapping of transcripts. Primer extension reactions were performed by the method of Crawford and Miller (11) . Cytoplasmic RNA was isolated at 48 and 72 h p.i. from 652Y cells infected with A21-MPV. An 18-base oligonucleotide (complementary to positions 132 to 149 in Fig. 2 ) was used in the reactions after being end labeled with [␥-
32 P]ATP (NEN). The primer was extended with Moloney murine leukemia virus reverse transcriptase. Primer extension products were fractionated on 6% polyacrylamide-8 M urea gels and visualized by autoradiography.
Construction of the enhancin::cat virus. A transplacement vector (pDB159) containing the enhancin gene disrupted with the cat gene was constructed. Transfections were carried out with 2.5 g of A21-MPV viral DNA and 2.5 g of pDB159 plasmid DNA by using the Lipofectin reagent (Bethesda Research Laboratories) as described previously (6) . At 7 days p.i., the cells and medium (3 ml) were collected and diluted with 12 ml of fresh medium in a T75 flask. The nonoccluded virus was collected at 7 days p.i. and plaque purified. Approximately 200 plaques were picked and used to infect 652Y cells in P96 plates. To identify recombinant viruses, budded virus (50 l) from the P96 wells was blotted by standard techniques and probed with the 0.7-kbp SstI fragment containing the cat gene from pDB4 (8) . For further details, see Results and Discussion.
Bioassay analysis of the enhancin::cat virus. Polyhedra were isolated from 652Y cells infected with either A21-MPV or the enhancin::cat virus and were purified and quantitated as previously described (34) . Fourth-instar L. dispar larvae were infected per os by placing them on a diet containing surface-applied in vitro-synthesized polyhedra (total of 5 ϫ 10 6 polyhedra). The larvae were placed on fresh food after 48 h on the infected diet. Dead larvae were collected and used as a source of in vivo polyhedra for the bioassays. The polyhedra were tested for biological activity by both the diet incorporation (23) and the droplet feeding (21, 22) methods.
In the diet incorporation bioassays, second-instar larvae were infected by placing them on a diet containing various concentrations of polyhedra (10 2 to 10 7 polyhedra per ml of diet) and allowing them to feed ad libitum for 48 h. Five groups (20 larvae each) were infected at each virus dose. After 48 h on the diet containing virus, the larvae were removed and placed on a fresh diet for the remaining 12 days of the bioassay. This type of bioassay was repeated in triplicate.
In the droplet feeding assay, neonate larvae (60 larvae per dilution) were allowed to feed for 30 min on droplets containing various dilutions of polyhedra (5 ϫ 10 3 to 10 6 polyhedra per ml of solution). The larvae were then placed on a fresh diet and were monitored for death for up to 18 days. The volume of solution ingested by L. dispar neonate larvae in the droplet feeding assay was determined by the method of Kunimi and Fuxa (26) .
Dead larvae from both bioassays were removed and counted daily. The 50% lethal concentrations (LC 50 s) and 50% lethal times were determined for each virus by Probit analysis (13) by using the POLO-PC program (LeOra Software, Berkeley, Calif. [33] ). The 50% lethal times and 50% lethal doses were also determined for the droplet feeding method by using the ViStat program (version 2.1; Boyce Thompson Institute, Cornell University, Ithaca, N.Y. [20] ).
Nucleotide sequence accession number. The nucleotide sequence accession number of the sequence contained in this paper is AF019971.
RESULTS AND DISCUSSION
Identification of the enhancin gene. The enhancin gene was identified during the mapping and sequencing of the gene mutated in LdMNPV few polyhedron mutants. Initially these mutations were mapped to a 4.3-kbp BamHI/EcoRI fragment located at 64.5 to 68.9 kbp on the viral genome. Further mapping studies revealed that these mutations were within the 25K FP gene between 65.3 and 66.0 kbp (6, 7) . During the sequencing of the 4.3-kbp fragment, an open reading frame (ORF) which initiated within this fragment and proceeded through the EcoRI site located at 68.9 kbp was discovered. The predicted amino acid sequence of this partial ORF was compared with those of other proteins in GenBank at the National Center for Biotechnology Information by using the BLAST network server (1) . This ORF exhibited homology to the enhancin genes of the TnGV, PuGV, and HaGV. The entire ORF was subcloned on a 4.2-kbp SstII fragment (67.0 to 71.2 kbp on the viral genome) into pBluescript SKϩ to generate pDB126, and the DNA sequence of the ORF was determined. The LdM-NPV enhancin gene is located between 67.6 and 70.1 kbp on the viral genome and is transcribed clockwise with respect to the circular viral genome (Fig. 1A) . A partial restriction map and the ORF map of a 2.46-kbp fragment in this region are presented in Fig. 1B , with the largest ORF (2,346 bp in frame 1) corresponding to the enhancin gene.
Characteristics of the nucleotide sequence. The nucleotide sequence of the 2,460-bp fragment containing the LdMNPV enhancin gene is presented in Fig. 2 Fig. 2] ). Potential late baculovirus promoter motifs have also been identified upstream of the enhancin genes in the TnGV (ATAAG [18] ) and the PuGV (ATAAG [32] ). In addition, enhancin transcripts have been shown to initiate within the HaGV late promoter motif TTAAG (at the nucleotides underlined within this sequence [32] ).
Immediately downstream of the LdMNPV enhancin gene is the hrf-1 gene (43), which is also transcribed in a clockwise direction (Fig. 1A) . There is no potential polyadenylation signal sequence that can be identified in the 119 bp between the enhancin stop codon and the hrf-1 start codon. This is similar to the TnGV, PuGV, and HaGV, which also lack canonical polyadenylation signal sequences between the enhancin gene and the downstream gene (ORF1) (18, 32) . Despite the similarity between the LdMNPV and the GVs with respect to the organization of the enhancin gene and its downstream gene (hrf-1 or ORF1), the LdMNPV hrf-1 gene shows no homology to the GV ORF1 genes.
Characteristics of the protein sequence. The LdMNPV enhancin gene encodes a shorter protein than the GV enhancin genes, with 782 aa for the LdMNPV enhancin compared to 901 or 902 aa for the GV enhancins. All four proteins show moderate homology at the N terminus and are less homologous at the C-terminal end (Fig. 3A) . The TnGV and PuGV enhancin proteins are virtually identical, with only 15 residue changes between the proteins for an overall 98% amino acid identity (18, 32) . The HaGV enhancin protein is less homologous to the other two GV proteins (TnGV and PuGV), with 81% amino acid identity (89% over the first 550 aa and 69% over the last 350 aa) and 90% similarity when conservative residue changes are taken into consideration (Fig. 3B) (32) . The LdMNPV enhancin protein shows approximately 31% amino acid identity (Fig. 3A) to each of the three GV enhancin proteins (32.1% to the TnGV protein, 32.2% to the PuGV protein, and 31.4% to the HaGV protein), with approximately 55% similarity (54.7% to the TnGV protein, 55.2% to the PuGV protein, and 55.6% to the HaGV protein). Overall the four proteins exhibit 29% amino acid identity, with four areas exhibiting greater than 50% amino acid identity (residues 59 to 67 at 78%, 196 to 290 at 51%, 451 to 468 at 58%, and 692 to 704 at 54% [ Fig. 3B]) .
Comparison of the LdMNPV enhancin amino acid sequence with sequences in the BLOCKS database (version 9.0, December 1995 [19] ) revealed the presence of a signature pattern characteristic of a zinc-binding domain found within metalloproteases (25, 30) . The signature pattern, HEXXH, is sufficient to group a protein into the metalloprotease superfamily. All four of the enhancin proteins have this conserved metalloprotease zinc-binding domain (residues 241 to 246 for the LdMNPV) within a larger region of the protein, and all four exhibit 51% amino acid identity in this region (residues 196 to 290 [ Fig. 3] ). For this type of enzyme, the zinc ion is chelated by the two histidine residues in this sequence and by a third residue, typically a histidine, cysteine, or aspartic or glutamic acid residue, located anywhere from 20 to 120 aa downstream of the HEXXH sequence (for reviews, see references 17 and 24). There are two aspartic acid and two glutamic acid residues between 20 and 120 aa from the HEXXH sequence which are conserved in all four enhancin proteins (LdMNPV residues 269, 289, 297, and 302), any of which could function as a third zinc-binding ligand in the enhancin proteins (Fig. 3A) . In the metalloproteases, the glutamic acid residue within the HEXXH sequence is the catalytic base which polarizes a water molecule involved in the nucleophilic attack of the peptide bond to be cleaved. Recently, it has been demonstrated that the TnGV enhancin gene encodes a metalloprotease (27) that is capable of degrading an insect intestinal mucin in the T. ni larval midgut (46) .
In vitro transcription and translation of the enhancin gene. To demonstrate that the enhancin ORF encoded a protein, the gene was expressed from pDB126 in a rabbit reticulocyte coupled transcription and translation system. Plasmid pDB126 contains the 4.2-kbp SstII fragment (67.0 to 71.2 kbp on the viral genome) and has the enhancin gene under the control of the T7 polymerase. Several radiolabeled bands, with apparent molecular masses ranging from 25 to 88 kDa, were visualized after analysis by SDS-PAGE and autoradiography (Fig. 4) . The size of the enhancin protein is predicted to be 89 kDa from the nucleotide sequence. The smaller bands may correspond to translation initiation at internal methionine-encoding bases within the enhancin ORF or could be degradation products of the enhancin protein itself. No radiolabeled bands were detected for the parent plasmid pBluescript SKϩ (Fig. 4) .
Temporal analysis and primer extension mapping of the enhancin transcripts. A 30-base oligonucleotide complementary to nucleotide positions 939 to 968 (Fig. 2 ) was used as a strand-specific probe to characterize the temporal expression of the LdMNPV enhancin gene. The enhancin gene is transcribed primarily as a 3.5-kb transcript at late times, 48 and 72 h p.i. (Fig. 5) . Two smaller RNA species (1.2 and 1.5 kb) also appear to be expressed at these times, although at lower levels. The gene does not seem to be transcribed at a high level, or else the transcripts are not very stable, since the blot shown in Fig. 5 contained 150 g of RNA per lane and required a long exposure (3 weeks) for detection of the transcripts. The 3.5-kb transcript is quite large, as the LdMNPV enhancin ORF is only 2.3 kbp in length. In comparison, the TnGV enhancin gene is expressed as two late transcripts, 2.7 and 3.3 kb in length, in closer agreement with the size of the 2.7-kbp enhancin ORF in this virus (18) .
To determine the transcriptional start site of the LdMNPV enhancin transcripts, primer extension reactions were performed with an 18-base oligonucleotide that is complementary to nucleotides 132 to 149 within the enhancin ORF (Fig. 2) . Transcription initiates at the first A residue (position 38 in Fig.  2 ) within the consensus baculovirus late promoter sequence TTAAG (Fig. 6 ). Since only one start site was detected, it is possible that the large enhancin transcript initiates at this late promoter upstream of the enhancin ORF, proceeds through the enhancin and hrf-1 genes, and terminates at a potential polyadenylation signal sequence (AATAAA) that has been identified downstream of the hrf-1 gene (43). This polyadenylation signal sequence is 3.2 kbp downstream of the enhancin late promoter. Analysis of HaGV enhancin RNAs by RNase protection assay also indicated that the HaGV enhancin gene and the downstream ORF1 gene may be part of the same bicistronic message (32) and therefore similar to enhancin gene transcription in LdMNPV.
Construction of the enhancin::cat virus. Since purified enhancin can increase the potency of the AcMNPV (45), a virus in which the LdMNPV enhancin gene was disrupted was constructed, in order to determine if the protein has an effect on LdMNPV potency. Plasmid pDB108 has the 4.3-kbp BamHI/ EcoRI fragment (located at 64.5 to 68.8 kbp on the viral genome) containing approximately 1.1 kbp of the portion of enhancin which encodes the N-terminal end (Fig. 7) . It also contains approximately 3.2 kbp of upstream sequence and has an SstI site 223 bp downstream of the enhancin ATG start codon (Fig. 2) . The insert used to disrupt the gene was a fragment containing the cat gene that was isolated on a 0.7-kbp SstI cassette from pDB4 (8) . The promoter-and terminatorless cat gene was cloned into the SstI site within the enhancin gene to generate pDB159. This construct has the cat gene inserted at codon 76 in the noncoding orientation with respect to the enhancin ORF (Fig. 7) . Since the cat gene is not translationally fused and in the opposite direction to the enhancin ORF, it can be used only as a marker to identify the recombinant virus (through hybridization) and not for studies of gene expression from the enhancin promoter. Analysis of the DNA sequence of the insert predicts that a small transcript (approximately 454 (Fig. 2) . The primer was extended with Moloney murine leukemia virus reverse transcriptase. Extension products were fractionated by PAGE and visualized by autoradiography. The sequencing ladder was generated with the same primer. The late transcriptional start site is underlined. C, control.
VOL. 71, 1997 AN enhancin GENE IN THE L. DISPAR NPVbp in length) could still be expressed that initiates at the enhancin late promoter and terminates at a consensus polyadenylation signal sequence present in the cat gene insert. A small fusion protein containing the first 76 aa of enhancin and 9 additional aa (from the cat gene insert) could be expressed from the enhancin promoter. This fusion protein does not contain the zinc-binding domain and is most likely not active. The mutant was constructed and verified by Southern blot analysis with the 4.3-kbp BamHI/EcoRI fragment as a probe (Fig. 8) . Viral DNA from A21-MPV and the enhancin::cat virus was isolated and restricted with both BamHI and EcoRI. In Fig. 8, lane 1, (A21-MPV) , only the 4.3-kbp BamHI/EcoRI fragment hybridized with the probe, as expected. The enhancin::cat virus (lane 2) has an additional EcoRI site at the start of the cat gene; therefore, two fragments hybridized in this isolate: (i) a 0.9-kbp EcoRI fragment and (ii) a 4.1-kbp fragment from the BamHI to the EcoRI site at the beginning of the cat gene (Fig.  8) . This result confirms that the mutation was transferred to the viral genome and that the enhancin ORF was disrupted with the cat gene in this isolate.
Bioassay analysis of the enhancin::cat virus. Bioassays (diet incorporation and droplet feeding) were conducted with L. dispar larvae infected with either A21-MPV or the enhancin::cat virus. Both the diet incorporation and droplet feeding methods revealed that inactivation of the enhancin gene resulted in a drop in viral potency ranging from 1.4-to 4.0-fold as determined by Probit analysis (Table 1) . Although it is hard to determine the exact degree of the drop in potency due to the close LC 50 s for both viruses, in all four bioassays the enhancin:: cat virus was less potent than A21-MPV. The fiducial limits of the LC 50 s for A21-MPV and the enhancin::cat virus did not overlap in the droplet feeding bioassay. The droplet feeding bioassay was used to verify the results of the diet incorporation bioassays since the former method is more accurate for close LC 50 s and yields smaller standard deviations than the diet incorporation method (22) . The drop in potency in the four FIG. 7 . Construction of the enhancin::cat virus. The 4.3-kbp BamHI/EcoRI fragment (64.5 to 68.9 kbp on the viral genome) containing the N terminus-encoding portion of the enhancin gene was cloned from LdMNPV isolate A21-MPV into pUC18 to generate pDB108. A 0.7-kbp SstI fragment containing the cat gene was cloned into the SstI site within the enhancin gene to generate pDB159. bioassays was analyzed by the unpaired t test (P ϭ 0.0125) and by analysis of variance (P Ͻ 0.05) and was found to be significant. In the droplet feeding method, the volume ingested by neonate L. dispar larvae was determined to be 176.5 Ϯ 37.1 nl (data not shown). Based on this volume, the 50% lethal doses were 17.9 Ϯ 2.4 polyhedra per larva for the enhancin::cat virus and 8.7 Ϯ 1.0 polyhedra per larva for A21-MPV. Analysis of the time-mortality response showed similar killing speeds for the two viruses (data not shown). Therefore, the enhancin protein has an effect on the potency of the virus but not on the killing speed of the virus.
Previously it was reported that LdMNPV is evolutionarily more distant from AcMNPV than are other NPVs, based on phylogenetic analysis of the known polyhedrin gene sequences from several baculoviruses (48) . The finding of an enhancin gene in the LdMNPV supports the polyhedrin gene phylogeny. In addition, the presence of the LdMNPV enhancin gene may suggest that the LdMNPV is more closely related to the GVs than is the AcMNPV. Since the LdMNPV has an additional 29 kbp of DNA that is not present in the AcMNPV, it is possible that other homologous genes possessed by both the GVs and the LdMNPV will be identified as more sequence data become available. 
